|
FDA Warns CardioMEMS for Recommendations to Investigators
The FDA handed Atlanta-based CardioMEMS a warning letter for deviations related to a clinical investigation and premarket approval application (PMA) for its CardioMEMS HF Pressure Measurement System.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives